Regal Healthcare Capital Partners closes Fund IV above target at $610M
What's the deal? Regal Healthcare Capital PartnersDealroom has a profile for this one. Try Dealroom → has closed its fourth private equity fund, RHCP IV, at $610 million in total commitments — above its original $550 million target. Around $575 million of that came from external investors.
Who backed it? The New York-based firm drew both existing investors and new blue-chip backers, including endowments, foundations, asset managers, consultants, and public pension plans. Regal said the fund expanded its investor base by geography and type.
What's the endgame? Regal invests exclusively in lower-middle market healthcare services companies across the US. It typically puts about $75 million into each deal, targeting businesses with $20–$100 million of revenue and $2–$10 million of EBITDA.
Why now? Since 2018, Regal has raised nearly $1.3 billion across its first four funds. Fund IV continues its strategy of partnering with healthcare entrepreneurs focused on accessible, convenient patient care.
"Fund IV reflects the confidence our investors have placed in our team and strategy, and we are excited about the opportunities ahead," said Jon SantemmaDealroom has a profile for this one. Try Dealroom →, general partner at Regal.
LazardDealroom has a profile for this one. Try Dealroom → served as exclusive placement agent for the raise, and Kirkland & EllisDealroom has a profile for this one. Try Dealroom → acted as legal counsel.
The signal: Beating target in a tight fundraising market signals steady investor appetite for specialist healthcare buyout firms, particularly those focused on the lower-middle market.
Read more: PR Newswire
Image credit: Regal Healthcare Capital Partners
